Paper-Based Assay Device Using Enzyme Cascade for Femtomolar Hormone Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for detecting and quantifying female reproductive hormones at low concentrations are costly, complex, and inaccessible in resource-limited settings, limiting women's ability to manage their reproductive health effectively.
Innovation Solution
A paper-based assay device with distinct zones that utilize an activator, amplifier, and biomatrix barrier to quantify analytes at femtomolar concentrations, requiring only a small sample volume and no external power sources, enabling simultaneous detection of multiple analytes with a simple readout.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional diagnostic methods are used for detecting female reproductive hormones, then measurement precision can be achieved, but device complexity and cost increase significantly
Solution Approach 1:
The device is divided into distinct functional zones: a loading zone for sample introduction, an amplifier zone containing zymogen, and a detection zone with indicator. This segmentation allows each zone to perform its specific function efficiently while maintaining overall system simplicity for detecting femtomolar hormone concentrations
Solution Approach 2:
An enzyme activator serves as an intermediary between the hormone analyte and the zymogen amplifier. The activator is displaced by the hormone and triggers zymogen activation, creating a cascade that amplifies the signal for detection at femtomolar levels without requiring complex instrumentation
2Measurement precision
If conventional diagnostic methods are used, then measurement precision is maintained, but ease of operation deteriorates due to requiring trained personnel and complex equipment
Solution Approach 1:
The device performs self-diagnosis through a visual color change indicator that automatically appears in the detection zone when hormones are present. The magnitude of color change directly indicates hormone concentration, eliminating the need for trained personnel or complex readout equipment while maintaining quantitative accuracy
Solution Approach 2:
A pH-sensitive indicator in the detection zone undergoes color change in response to enzyme activity triggered by hormone presence. The intensity and extent of color change provide direct visual quantitation of hormone levels, making the device easy to operate for users without specialized training
3Reliability
If conventional diagnostic methods are used, then reliability of results is achieved, but loss of time increases due to lengthy procedures
Solution Approach 1:
The zymogen is pre-loaded in the amplifier zone in an inactive state, ready for immediate activation. When sample is added, the enzyme activator-displacement cascade begins instantly, and the color change indicator provides rapid visual results within minutes, maintaining reliability while dramatically reducing assay time compared to conventional methods
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device provides reliable, cost-effective, and portable means for real-time quantitation of female reproductive hormones and other analytes, empowering women with reproductive health data and facilitating informed policy and medical decisions.
Implementation Method 1
The activator may be immobilized and then displaced via disruption of covalent or non-covalent interactions
Implementation Method 2
The activator may be immobilized and then displaced via disruption of covalent or non-covalent interactions
Implementation Method 3
The activator may include enzymes that activate zymogens such as enterokinase
Implementation Method 4
a biomatrix barrier that may be chemically or conformationally modified by the amplifier
Implementation Method 5
a biomatrix barrier that may be chemically or conformationally modified by the amplifier
Implementation Method 6
the biomatrix barrier may be a biopolymer that forms an aqueos impermeable or semipermeable barrier such as gelatin
Implementation Method 7
an indicator responsive to the alteration of the barrier
Data Source
AI summary
An assay device including a loading zone for a sample that may contain an analyte, an activator in communication with the loading zone from which at least one activator is displaced by presence of the analyte, an amplifier in an inactive state in communication with the activator that becomes activated in the presence of the activator, a biomatrix barrier in communication with the activated amplifier that is degraded or modified by the activated amplifier, and an indicator responsive to the degradation or modification of the biomatrix barrier, which in turn reflects a concentration of the analyte in the sample loaded on the device. The selection of analyte or displacement of the activator by presence of the analyte may occur off-platform and/or may rely on use of non-covalent interactions. The activator may include an enzyme or other reagent that activates the amplifier. Also, associated methods.